100% successful submissions for the early benefit assessment

You are considering launching an innovative highly invasive medical device in Germany?
There is a high chance that you will have to undergo an early benefit assessment by the federal joint committee (G-BA) according to §137h SGB V.
Last year inspiring-health supported 40% of all §137h submissions to the federal joint committee and now we have confirmation that all our submissions have been successful, and the products are eligible for an assessment trial. Together with our customers we are now starting consultation meetings with the federal joint committee on study protocols and conditional reimbursement during the study phase.
The annual deadline for submissions is October 31st. This is the exact right time to contact our experts Prof. Dr. Michael Wilke and Markus Rathmayer to also support your product. We at inspiring-health have many years of experience in the benefit assessment of medical devices and the associated submissions as well as dialogue processes with the authorities. We would be happy to support you getting your great technology to patients.

Please feel free to contact us
And follow us on LinkedIn: https://www.linkedin.com/company/inspiring-health-gmbh